baber/WOPTO huggingface dataset:
Patent EP-0852564-B1 (EP)
Inventor: ROSER ERICH
IPC: B65H51/22
Filed: 1996-09-25
Granted: 2000-07-12
Abstract: L'invention concerne un dispositif d'alimentation (1) pour un matériau à enrouler (25) de type fil. Ce dispositif permet de conserver un minimum de réserve de matériau à enrouler (25) dans un dévidoir (27), et ce, de telle façon que l'extrémité du matériau à enrouler ne forme pas un bourrage et puisse être tiré dans le sens axial sans s'effilocher. Pour ce faire, l'invention propose qu'un disque de commande (7) à déplacement axial soit pourvu d'au moins un élément oblique de guidage (12). La course axiale du disque de commande (7) est détectée par un capteur (9,10) et/ou un interrupteur et est convertie en un signal caractérisant l'épaisseur d'enroulement.
Patent EP-0882707-B1 (EP)
Inventor: MIYOSHI SHIRO
IPC: C07C317/28
Filed: 1996-12-18
Granted: 2003-10-08
Abstract: Compounds represented by general formula (I) or salts thereof, a process for producing the same, and intermediates therefor, wherein R represents hydrogen or methyl; R<1> represents hydrogen, hologeno, hydroxy, benzyloxy, amino, or hydroxymethyl; R<2> represents hydrogen, hydroxymethyl, NHR<3>, SO2NR<4>R<4>, or nitro; R<6> represents hydrogen or lower alkyl; and X represents nitrogen, oxygen, sulfur, or methylene, provided that when X represents nitrogen, oxygen, or sulfur, then R<9> represents hydrogen, one of R<7> an R<8> represents hydrogen, and the other thereof represents hydrogen, amino, acetylamino, or hydroxy, and when X represents methylene, then R<7> and R<8> each represents hydrogen and R<9> represents hydrogen, amino, etc. They have a  beta -3 adrenaline receptor agonist and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. <CHEM>
Patent EP-0856294-B1 (EP)
Inventor: SCHALLER RAIMUND DIPL-ING DR
IPC: A61B42/00
Filed: 1997-09-15
Granted: 2001-08-08
Abstract: A component (1) made of flexible rubber and/or plastic and used in contact with human skin, e.g. a condom or glove, has specific surface areas (12) covered by a polymer sliding layer (9) with a roughened surface created by deformations (19,20). In a manufacturing process, a carrier layer (3) is produced in plastic and/or rubber by dipping a former with surface deformations. A sliding layer (9) is then applied to this by dipping, the deformations (19,20) corresponding to those(14) created in the carrier layer (3). After drying in hot air for 10-600sec, the component is dipped in or flushed with water at 40-100, preferably 60-80 degrees C to initiate reaction in the layers (3,9). During this stage the water content of the sliding layer (9) is reduced by 40-70%, preferably 50-60%.
Patent EP-0832882-B1 (EP)
Inventor: BRYANT HENRY UHLMAN
IPC: C07D295/08
Filed: 1997-09-25
Granted: 2002-04-03
Abstract: The invention provides naphthofluorene compounds, intermediates, formulations, processes, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia, and estrogen-dependent cancer.
Patent EP-0818200-B1 (EP)
Inventor: PINEAU NATHALIE
IPC: A61K6/00
Filed: 1997-07-04
Granted: 2002-04-10
Abstract: Utilisation of ≥ 1 polyholoside (P) in cosmetic or therapeutic compositions for countering intrinsic and/or extrinsic cutaneous ageing by aiding desquamation and/or stimulating epidermal renewal, is new.
Patent EP-0876289-B1 (EP)
Inventor: ANDREASSON SUNE
IPC: F16C33/10
Filed: 1997-01-24
Granted: 2000-03-22
Abstract: PCT No. PCT/SE97/00113 Sec. 371 Date Sep. 21, 1998 Sec. 102(e) Date Sep. 21, 1998 PCT Filed Jan. 24, 1997 PCT Pub. No. WO97/27129 PCT Pub. Date Jul. 31, 1997A bearing device in such linear actuators which comprises an elongated hollow profile rail, in which a slide member can be moved backwards and forwards along flat guiding surfaces in the hollow profile rail. In pairs, the guiding surfaces form an angle with one another. Between the hollow profile rail and the slide member are slide bushings arranged in pairs. The slide bushings each include a flat face that abuts against the guiding surfaces of the hollow profile rail, and a curved face that abuts against a correspondingly configured seat in the slide member.
Patent EP-0830399-B1 (EP)
Inventor: SIOL WERNER
IPC: C08F220/12
Filed: 1997-02-05
Granted: 2002-09-18
Abstract: PCT No. PCT/EP97/00503 Sec. 371 Date Dec. 22, 1997 Sec. 102(e) Date Dec. 22, 1997 PCT Filed Feb. 5, 1997 PCT Pub. No. WO97/31043 PCT Pub. Date Aug. 28, 1997The invention relates to a molding mass which can be thermoplastically processed, characterized in that it consists of monomer units of a) 80-99.9 wt.- % methyl methacrylate, b) 0.1-20 wt.- % ethylene, c) 0-19.9 wt.- % other comonomers. The invention further relates to a method for the production of the molding mass, as well as molded elements made from it.
Patent EP-0880624-B1 (EP)
Title: Building kit
Inventor: ANDRAE HANS-PETER
IPC: E04B1/04
Filed: 1997-02-06
Granted: 2000-06-07
Abstract: The invention concerns a kit for buildings to be erected according to the prefabricated method, the kit essentially comprising table-like element frames (1). Each element frame (1) comprises a ceiling panel (2) which is connected in a flexion-resistant manner to an outer pillar (3). An inner pillar (4) is connected to the ceiling panel (2) in the region of the other end.
Patent EP-0819119-B1 (EP)
Inventor: AKHAVAN-TAFTI HASHEM
IPC: C09K3/00
Filed: 1997-01-15
Granted: 2003-04-02
Abstract: Novel heterocyclic compounds which generate chemiluminescence on reaction with a phosphatase enzyme are provided as well as a process for their preparation and intermediates useful therein. The compounds comprise a nitrogen, oxygen or sulfur-containing heterocyclic ring system bearing an exocyclic carbon-carbon double bond. The double bond is further substituted at the distal carbon with a phosphate group and an oxygen or sulfur atom-containing group. Novel compositions further comprising a cationic aromatic compound (CAC) in addition to the heterocyclic phosphate compound are provided. The addition of the CAC in the composition greatly increases the production of chemiluminescence and provides improved detection sensitivity. Compositions further comprising an anionic surfactant and a non-ionic surfactant provide additional improvements in detection sensitivity. The novel chemiluminescent compounds and compositions are useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs.
Patent EP-0901444-B1 (EP)
Title: Transmission a entrainement integre a mecanisme de direction conique
Inventor: FINCH THOMAS E
IPC: B60K1/00
Filed: 1997-03-06
Granted: 2004-11-10
Abstract: L'invention concerne un véhicule électrique présentant deux roues primaires (5) au contact du sol, reliées fonctionnellement à un moteur d'entraînement (10) par une transmission automatique (50), et à un moteur de direction (20) par un engrenage conique réversible (7b) permettant des variations opposées de la vitesse de rotation des roues (5) au contact du sol.
Patent EP-0891302-B1 (EP)
Inventor: TROESCH WALTER
IPC: C02F3/10
Filed: 1997-04-02
Granted: 2003-08-20
Abstract: PCT No. PCT/DE97/00671 Sec. 371 Date Jan. 26, 1999 Sec. 102(e) Date Jan. 26, 1999 PCT Filed Apr. 2, 1997 PCT Pub. No. WO97/37941 PCT Pub. Date Oct. 16, 1997The present invention relates to a process for the biological purification of wastewater in which a liquid stream is fed to the aerobic biological purification stage, which liquid stream has already been freed in advance from undissolved substances using a membrane separation process.
Patent EP-0892815-B1 (EP)
Inventor: BERG HANS
IPC: B01D15/08
Filed: 1997-04-07
Granted: 2004-03-17
Abstract: A process for the production of a porous cross-linked polysaccharide gel and a gel obtainable by the following steps: a) preparing a solution or dispersion of the polysaccharide; b) adding a bifunctional cross-linking agent having one active site and one inactive site to the solution or dispersion from step a); c) reacting hydroxylgroups of the polysaccharide with the active site of the cross-linking agent; d) forming a polysaccharide gel; e) activating the inactive site of the cross-linking agent; f) reacting the activated site from step e) with hydroxylgroups of the polysaccharide gel, whereby cross-linking of the gel takes place. The cross-linked polysaccharide gel obtained can further be cross-linked by conventional methods, one or several times.
Patent EP-0901500-B1 (EP)
Inventor: ZHANG ZHAODA
IPC: C07F9/572
Filed: 1997-04-28
Granted: 2003-11-19
Abstract: The invention provides novel bifunctional phosphitylating reagents and their application in in situ preparation of 5'-protected nucleoside phosphoramidites and synthesis of oligonucleotides. Bifunctional phosphitylating reagents according to the invention react quickly with nucleosides under weakly acidic conditions. In addition, the bifunctional phosphitylating reagents according to the invention generate chemoselectively the corresponding nucleoside phosphoramidites in situ, without need to purify the nucleoside phosphoramidites before using them in oligonucleotide synthesis. Finally, the bifunctional phosphitylating reagents according to the invention are relatively stable and easy to handle.
Patent EP-0914818-B1 (EP)
Inventor: OHTA MOTOHIRO
IPC: A61K9/00
Filed: 1997-06-12
Granted: 2005-06-08
Abstract: A tablet comprising sugar alcohol or saccaride having an average particle diameter of not more than 30  mu m, an active ingredient, and a disintegrant. It is an intraorally rapidly disintegrable tablet which does not require a special pharmaceutical manufacturing technology and can be simply and easily produced by a normal equipment.
Patent EP-0920501-B1 (EP)
Inventor: THEILL LARS EYDE
IPC: C12N15/12
Filed: 1997-08-07
Granted: 2003-10-29
Abstract: Disclosed are DNA and amino acid sequences for a novel polypeptide termed Neuritin which is expressed primarily in selected regions of the brain.
Patent EP-0915817-B1 (EP)
Inventor: GUTMANN PEDRO
IPC: C07C29/78
Filed: 1997-07-21
Granted: 2001-06-13
Abstract: PCT No. PCT/EP97/03924 Sec. 371 Date Apr. 19, 1999 Sec. 102(e) Date Apr. 19, 1999 PCT Filed Jul. 21, 1997 PCT Pub. No. WO98/03457 PCT Pub. Date Jan. 29, 1998The continuous process for making crystalline D-sorbitol using a melt crystallizer consisting of a cooled container and a horizontally arranged rotatable shaft equipped with disk elements and mixing parts to form a worm includes evaporating an aqueous D-sorbitol solution at 5 to 200 mbar and at a temperature of 130 DEG  to 170 DEG  C. in vacuum, advantageously in a thin film evaporator, to obtain a D-sorbitol melt containing less than 0.5 % by weight water; cooling the D-sorbitol melt to a temperature of 5 to 15 DEG  C. above a solidification point of the D-sorbitol melt; melt crystallizing the D-sorbitol melt obtained during the evaporating in the melt crystallizer with an average dwell time of 1 to 5 hours to form D-sorbitol crystals and grinding and sieving the D-sorbitol crystals formed during the melt crystallizing of step d) to form a D-sorbitol end product containing more than 90% by weight of a  gamma  modification of crystalline D-sorbitol. During the process no solid D-sorbitol is added to the D-sorbitol melt in order to form initial crystallization nuclei for crystallization and no subsequent maturation steps of the end product are included in the process.
Patent EP-0923556-B1 (EP)
Inventor: DOLLING ULF H
IPC: C07D263/06
Filed: 1997-08-05
Granted: 2003-10-08
Abstract: This invention relates to a key intermediate in the synthesis of an endothelin antagonist and the synthesis of this key intermediate using an asymmetric conjugate addition reaction.
Patent EP-0918643-B1 (EP)
Inventor: FRANCIS JOHN
IPC: G03C1/795
Filed: 1997-08-12
Granted: 2001-11-21
Abstract: Un film de polyester comporte une couche centrale opaque ayant une densité optique supérieure à 2,0 et, sur ses deux faces, une couche blanche externe. La couche centrale contient de préférence du noir de carbone. Ce film convient particulièrement bien pour représenter des images sur ses deux faces.
Patent EP-0956036-B1 (EP)
Inventor: GEESIN JEFFREY C
IPC: A61K38/00
Filed: 1997-10-24
Granted: 2005-12-14
Abstract: A novel method has been developed for screening anti-scarring and anti-fibrotic agents. This method offers simplicity, it is reproducible and could be adopted to screen a large number of new potential anti-fibrotic agents. This method has characteristics in common with the BAEC/BASMC co-culture system, but is more sensitive and does not require screening a large number of clonal lines for developing an effective method. In this system, similarly to the co-culture system, activation of L-TGF- beta 1 occurs by several independent mechanisms which involve binding of the latent complex to M6P/IGF-II receptors, thrombospondin and/or tissue type II transglutaminase. But, in contrast to the co-culture system, this macrophage-dependent system does not appear to involve plasmin. Using this method, potential novel anti-fibrotic agents such as IGF-II (used separately or in combination with IGFBP-2 as a delivery vehicle), tissue type II transglutaminase inhibitors and anti-inflammatory agents (such as hydrocortisone) were identified. A potential novel mechanism of action for Mannose 6-Phosphate has been proposed which is based on downregulation of M6P/IGF-II receptor and TGF- beta 1 mRNAs.
Patent EP-0883456-B1 (EP)
Inventor: HORN WOLFGANG
IPC: B23Q39/00
Filed: 1997-11-19
Granted: 2002-04-03
Abstract: The invention concerns a machine tool comprising a plurality of spindles which are disposed parallel to one another and preferably vertically for the transport of the workpieces or tools to and from the machining point and for the simultaneous or different, separate machining of a plurality of workpieces. The spindles, which can be driven about their axes of rotation and displaced in their axial direction, can be displaced on horizontal guide tracks together or relative to one another. According to the invention, all the spindles (10, 11) can be displaced such that they are supported independently of one another, in each case with a separate carriage (3, 4) on guide tracks (2) disposed at different levels and on one side on a securing plane. The carriages (3, 4) are imbricated in one another such that the outer carriage(s) (3) surrounds (surround) the inner carriage(s) (4) in frame-like manner.
Patent EP-0882953-B1 (EP)
Inventor: EFF ULRICH
IPC: G01F15/06
Filed: 1998-05-20
Granted: 2006-04-26
Abstract: The magnetic coupling is provided for a water meter or the like. The coupling has two magnets (4,5) which rotate on either sides of a dividing wall between the measuring part and the analysis and display part. The magnets are surrounded by magnet protective rings (9). The magnets are covered by a closing disc (10,11) on the sides applied to the respective counter-coupling parts. Preferably, the protective ring surrounds the stepped cover wall (6) of the measuring part (1) and the stepped base wall (7) of the counter mechanism (3). Two protective rings may be provided on both sides of the same dividing wall.
Patent EP-0901861-B1 (EP)
Inventor: HEULE HEINRICH
IPC: B23D79/00
Filed: 1998-09-03
Granted: 2008-10-29
Abstract: A rack (25,26) and pinion (28) gear mechanism, operated by the radial motion of two symmetrical spring loaded bob-weights, varies the rotational position of the cutter control shaft (40) relative to the body of the tool. The tool has one or more cutters (12) which are carried in a rigid shank (3). Radial protrusion (43) of the cutting edge (13) from the shank is governed by the position of an eccentric pin (42) fixed to the control shaft and is adjusted by varying the rotational speed of the tool. The control shaft is driven through a coupling (48). The bob-weights slide radially on guide pins (19,20). The cutters can be replaced by moving the control shaft axially on its drive pins (33,34) against a spring (39), to disengage the eccentric pin, allowing the cutter to slide out of its guide (10).
Patent EP-0949402-B1 (EP)
Title: Safety device for a crank shaft for actuating roller blinds and stores
Inventor: THOENEN WALTER
IPC: E06B9/76
Filed: 1998-04-09
Granted: 2003-05-14
Abstract: The crank shaft (12) contains a non-rotation symmetrical hollow region (14) extending along its length, into which a seat (6) protruding from the direction changing mechanism fits snugly. The safety device comprises a ring (18) with a pin (19) extending radially inwards, which can be fixed inside borings (17) in the crank shaft and seat. The safety device is fitted to the direction changing mechanism for the drive mechanism for the blinds or curtains, and its purpose is to prevent the crank shaft being pulled out of the universal joint seat. A boring is provided in the crank shaft, extending at right angles to the crank shaft length axis (9), and a boring is also provided in the seat.
Patent EP-1025003-B1 (EP)
Inventor: LUNDBERG T JOERGEN
IPC: B65D85/07
Filed: 1998-03-26
Granted: 2003-10-08
Abstract: Methods are disclosed for securing a wrapper about a bale which is intended to be subsequently treated comprising inserting a fastener pin through the wrapper into the bale, the fastener pin being adapted to remain in the bale during subsequent treatment thereof. Fasteners are also disclosed for securing wrappers about bales.
Patent EP-1012189-B1 (EP)
Inventor: NG FRANK MAN-WOON
IPC: A61P43/00
Filed: 1998-09-04
Granted: 2007-10-31
Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
Patent EP-1041880-B1 (EP)
Inventor: FOSSEL ERIC
IPC: A61Q19/00
Filed: 1998-09-17
Granted: 2010-01-27
Abstract: A delivery vehicle and method for delivering, either topically or orally, a nitric oxide releasing substance such as L-arginine 31 into human or mammalian tissue for the purpose of producing beneficial effects such as the relief of pain, the warming of cold tissues, the growth of hair on the scalp, the healing of leg ulcers, the relief of impotence as well as other beneficial effects. The delivery vehicle provides a hostile biophysical environment which facilitates and promotes the migration of the nitric oxide releasing substance into the tissue.
Patent EP-0958590-B1 (EP)
Inventor: VAN DER MAST KAREL DIEDERICK
IPC: H01J37/244
Filed: 1998-10-19
Granted: 2003-06-11
Abstract: Dans un microscope électronique à balayage environnemental (ESEM environmental scanning electron microscope), le courant d'électrons secondaires émanant d'un échantillon (14) à examiner est amplifié par ionisation, de type avalanche, des molécules (41) de l'atmosphère gazeuse. Cependant, afin d'effectuer un nombre adapté d'ionisations successives, une valeur relativement élevée du champ électrique est nécessaire au niveau de l'électrode de détection (46) et, en raison des risques de rupture électrique, la distance entre l'échantillon et l'électrode de détection ne peut pas être inférieure à une distance minimale relativement large. En conséquence, le nombre d'ionisations successives est limité et de ce fait, le courant d'amplification l'est également. La présente invention consiste à configurer le champ électrique du détecteur (46, 50) coopérant avec le champ magnétique (52) de la lentille d'immersion (8) déjà présente dans l'espace d'ionisation, comme un champ électrique multipolaire. Dans le cas de multipoles électriques, et pour une intensité donnée du champ sur l'axe optique, l'intensité du champ électrique en dehors de l'axe optique peut être sensiblement plus élevée. Ainsi, tout en n'influençant que légèrement le faisceau d'électrons primaires, il est possible d'obtenir un champ de détecteur d'intensité élevée de sorte que les électrons secondaires à accélérer reçoivent une énergie adaptée à la réalisation de nombreuses ionisations multipolaires, et par conséquent à la production d'un courant d'amplification élevé dans l'atmosphère gazeuse autour de l'échantillon.
Patent EP-1060878-B1 (EP)
Inventor: YANAGASE AKIRA
IPC: B29C45/14
Filed: 1998-10-22
Granted: 2010-09-22
Abstract: L'invention concerne une feuille photodurcissable, notamment une composition (A) de résine photodurcissable composée d'une résine (a-1) acrylique possédant un groupe fonctionnel photopolymérisable sur chaque chaîne latérale et un initiateur (a-2) de photopolymérisation, cette composition étant placée sur une feuille (B) de base transparente; une feuille décorative photodurcissable et une feuille photodurcissable servant au moulage par insertion, celles-ci étant produites à partir de la feuille de l'invention; des moulages produits à partir de celle-ci; et des procédés de production des moulages.
Patent EP-1066123-B1 (EP)
Inventor: PETERS DARRYL WAYNE
IPC: B08B3/08
Filed: 1998-10-13
Granted: 2011-11-16
Abstract: An aqueous stripping composition comprising a mixture of an organic amine and a corrosion inhibitor which is benzotriazole alone or in combination with gallic acid, its ester or analog. The stripping composition is effective to strip photoresists, residues from plasma process generated organic, metal-organic materials, inorganic salts, oxides, hydroxides or complexes in combination with or exclusive of organic photoresist films at low temperatures with little corrosion of copper or titanium containing substrates.
Patent EP-1015640-B1 (EP)
Inventor: ELLINGER THOMAS
IPC: C12Q1/6844
Filed: 1998-09-21
Granted: 2010-08-04
Abstract: The invention relates to a method for synthesising and amplifying nucleic acids by means of an enzyme-catalysed reaction wherein a nucleic acid is copied on the basis of a single-stranded initiator nucleic acid without said initiator nucleic acid hybridising with the nucleic acid being copied. According to the inventive method, a linear nucleic acid is copied on the basis of an initiator nucleic acid with a single-stranded area at least at the 3' end, through the activity of a polymerase. The initiator nucleic acid does not need to be homologous with the nucleic acid being copied.
Patent EP-1037941-B1 (EP)
Inventor: KORBEE ROLAND ALEXANDER
IPC: C08K3/34
Filed: 1998-12-08
Granted: 2007-10-24
Abstract: The invention relates to a process for the preparation of a polyamide nanocomposite composition by mixing in the melt phase a polyamide, a solid substance composed of anisotropic particles with a high aspect ratio and a liquid, the liquid being added to and subsequently mixed with a melt comprising at least the polyamide. Preferably water is chosen as the liquid.The invention also relates to a polyamide nanocomposite composition obtained by mixing in the melt phase a polyamide and a non-swollen solid substance composed of particles with a high aspect ratio.The polyamide nanocomposite compositions obtained with the process according to the invention and the polyamide nanocomposite compositions according to the invention can be used in all moulded parts which can be produced with a polyamide composition and which demand particularly good mechanical properties, for example for use in the motor compartment of a vehicle, for casings and for connectors.